Home » Topics » BioWorld Science

BioWorld Science
RSS

HIV protease inhibitors described by Hoechst Marion Roussel

April 19, 1996

VP-63843 effective in phase II

April 19, 1996

Sankyo claims HIV protease inhibitors

April 19, 1996

Bayer claims anti-HIV quinolone carboxylic acids

April 19, 1996

DepoAmikacin phase I trial completed

April 19, 1996

Abelcet trial results in children favorable

April 19, 1996

Cefdinir close to filing in U.S.

April 19, 1996

Teva's generic minoxidil approved in U.S.

April 19, 1996

Vivus files NDA for Muse

April 12, 1996

Testosterone transdermal patch approved in Sweden

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...